The short answer
Vulvar color and texture vary widely between people, and variation is not pathology. ACOG describes broad normal differences in vulvar anatomy and appearance. 1 At the same time, a new or persistent change in color or texture—especially with ongoing itching, burning, a bump, ulcer, bleeding, or focal pain—can be a reason for examination. 1
The central rule is simple: color is descriptive information, not a diagnosis.
Start with change from your own baseline
Skin tone, pigmentation, hair-bearing skin, friction, hormones, prior inflammation, and normal anatomy all affect appearance. It is more useful to ask whether a patch is new, changing, thickening, thinning, ulcerating, bleeding, or persistently symptomatic than to compare it with an internet color chart.
ACOG advises evaluation for vulvar skin color changes—including red, dark, or light spots—or new bumps, swelling, itching, or burning that do not go away. 1 That is a reason for examination, not a claim that the change is malignant.
Many inflammatory conditions change color or texture
Dermatitis can produce redness, rawness, thickening, or scratch changes. Lichen sclerosus can produce thin white fragile skin and architectural change. Psoriasis can produce smooth, well-demarcated genital plaques with less visible scale. These conditions overlap enough that appearance alone should not assign the diagnosis. ACOG advises clinicians to examine vulvar itching and visible skin changes because several skin conditions can look similar; color alone cannot identify the cause. 3
For condition-specific guides, see vulvar dermatitis and itching, vulvar psoriasis and itching, and vulvar lichen sclerosus and itching.
Concerning lesions can look different
ACOG notes that vulvar HSIL/VIN can be elevated or flat and can range from white or gray to red, brown, or black. 2 Vulvar HSIL/VIN does not have one diagnostic color. That variation is precisely why a “this color means cancer” chart is unsafe—and why a reassuring color cannot rule neoplasia out either.
Cancer is one rare possibility among many causes of vulvar change. A web page cannot convert an appearance into an individual's cancer probability.
When biopsy enters the discussion
ACOG lists several reasons to consider a biopsy of a visible lesion. These include an uncertain clinical diagnosis, possible malignancy, failure to respond to usual treatment, atypical vascular patterns, or a rapid change in a previously stable lesion's color, border, or size. 2
A clinician decides whether a biopsy is useful by examining the specific color or texture change and its history. It means visual uncertainty sometimes reaches a point where tissue sampling can answer a question that inspection alone cannot. For more on the procedure, see when a vulvar biopsy may be considered.
How changes over time guide evaluation
A lesion that has looked identical for years is different history from one changing over weeks, but stability does not erase persistent itching, ulceration, bleeding, or other concerning features. Conversely, change does not automatically mean cancer. The complete pattern determines the next evaluation.
What should you take away?
Vulvar color and texture should be interpreted relative to the person's baseline and the rest of the clinical picture, not against a skin-tone diagnostic chart. Persistent or changing visible findings deserve examination, but color alone cannot diagnose dermatitis, psoriasis, lichen sclerosus, VIN, or cancer—and it cannot generate a personal cancer probability.
What are the limits of this information?
Use this information to understand the topic and prepare for next steps. If you notice a new or changing spot, patch, or texture change on your vulva, schedule a gentle, respectful skin exam with your gynecologist or dermatologist. See the medical information disclaimer.
Sources
- ACOG: Vulvovaginal Health. Evidence reviewed 2026-09-14. Normal vulvar variation and guidance to seek evaluation for persistent color/texture changes, bumps, itching, or burning.
- ACOG: Management of Vulvar Intraepithelial Neoplasia. Evidence reviewed 2026-09-14. Wide lesion-color/appearance variation and biopsy indications when diagnosis is uncertain, malignancy is possible, therapy fails, or lesions change.
- ACOG: Disorders of the Vulva. Evidence reviewed 2026-09-14. Broad inflammatory vulvar differential and examination/biopsy boundary.